NCT02904512View on ClinicalTrials.gov

Inpatient Diabetes Mellitus (DM) Management With Continuous Glucose Monitoring Devices, a Pilot Study.

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

December 22, 2017

Study Completion Date

December 22, 2017

Conditions
Diabetes Mellitus
Interventions
DEVICE

Continuous glucose Monitoring (CGM) device and Point of Care (POC) blood glucose

Testing Blood Glucose levels with Continuous glucose Monitoring (CGM) device and Point of Care (POC) blood glucose

OTHER

Point of Care (POC) blood glucose

Testing Blood Glucose levels with Point of Care (POC) blood glucose

Trial Locations (1)

21201

Baltimore VA Medical Center, Baltimore

All Listed Sponsors
collaborator

DexCom, Inc.

INDUSTRY

lead

University of Maryland, Baltimore

OTHER

NCT02904512 - Inpatient Diabetes Mellitus (DM) Management With Continuous Glucose Monitoring Devices, a Pilot Study. | Biotech Hunter | Biotech Hunter